NXL (Nexalin Technology) Tariff Resilience Score: 4/10 (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NXL Nexalin Technology Inc NXL
38 GF Score
Price $0.33
GF Value $0.66
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Nexalin Technology Tariff Resilience Score?

Nexalin Technology NXL +0.18% 38 Tariff Resilience Score is 4 as of Aug. 20, 2026. GuruFocus rates NXL with a GF Score™ of 38/100 and a GF Value™ of $0.66 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 827 Medical Devices & Instruments companies, Nexalin Technology ranks better than 70.01% on this metric.

Nexalin Technology has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Nexalin Technology has Nexalin Technology's reliance on imported components for its medical devices makes it vulnerable to tariffs. The company has limited pricing power and few alternative suppliers, increasing its exposure to trade disruptions.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Nexalin Technology might have Average Resilient.

Nexalin Technology  (NAS:NXL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Nexalin Technology Tariff Resilience Score Related Terms

NXL vs ICCM, ADGM, ALRTF: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Nexalin Technology's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nexalin Technology Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nexalin Technology's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Nexalin Technology's Tariff Resilience Score falls into.


NXL
38GF Score
Nexalin Technology Inc NXL
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
Nexalin Technology (NXL) has a Tariff Resilience Score of 4 as of Aug. 20, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Nexalin Technology ranks #248 out of 827 companies in the Medical Devices & Instruments industry, placing it in the top 30%.
Is Nexalin Technology's Tariff Resilience Score too high?
Nexalin Technology's current Tariff Resilience Score is 4. Based on the distribution chart, Nexalin Technology ranks #248 out of 827 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nexalin Technology has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nexalin Technology's Tariff Resilience Score compare to ICCM and ADGM?
According to the Medical Devices & Instruments industry distribution chart, Nexalin Technology ranks #248 out of 827 companies for Tariff Resilience Score. This puts Nexalin Technology in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Nexalin Technology's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexalin Technology stock overvalued right now?
Based on GuruFocus' analysis, Nexalin Technology (NXL) is currently considered Possible Value Trap. The stock's GF Value™ is $0.66, compared to a current price of $0.33 — trading 49.6% below its estimated fair value. The current Tariff Resilience Score is 4. Nexalin Technology's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Nexalin Technology (NXL), the current Tariff Resilience Score is 4 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nexalin Technology (NXL) Overvalued in 2026?

Based on GuruFocus' analysis, Nexalin Technology stock appears to be undervalued. The current stock price of $0.33 is trading 49.6% below its estimated GF Value™ of $0.66. GuruFocus considers Nexalin Technology to be Possible Value Trap.

Key valuation signals for NXL:

  • Tariff Resilience Score: 4
  • GF Value™: $0.66 vs. price of $0.33 (49.6% below fair value)
  • GF Score™: 38/100 with 7 warning signs

No single metric tells the full story. See the NXL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nexalin Technology Business Description

Address 1776 Yorktown, Suite 550, Houston, TX, USA, 77056
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
38GF Score

Get the complete analysis for NXL

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.33
Price
$0.66
GF Value